Global Non-Invasive Aesthetic Treatment Market size is valued at USD 25.7 Bn in 2024 and is predicted to reach USD 63.8 Bn by the year 2034 at a 9.9% CAGR during the forecast period for 2025-2034.
Non-invasive aesthetic treatments encompass a wide range of cosmetic procedures and therapies intended to improve a person's look without requiring intrusive techniques or surgical incisions. Many technologies, including lasers, ultrasound, radiofrequency, and injectables like dermal fillers, Botox and are frequently used in these procedures to treat a variety of issues, such as wrinkles, fine lines, sagging skin, excess fat, and more. The market for non-invasive aesthetic treatment has grown significantly due to a number of important considerations.
The rising number of non-surgical aesthetic procedures carried out globally is one important factor. An estimated 18,857,311 non-surgical aesthetic procedures were performed worldwide, according to data from the International Society of Aesthetic Plastic Surgery. Since non-invasive therapies are less risky and need less recovery time than surgical options, this data illustrates their rising popularity. Therefore, the benefits of the non-invasive approach are fueling the market expansion for non-invasive aesthetic treatment.
Additionally, it is anticipated that social media will be crucial in raising awareness of non-invasive aesthetic treatments. In order to attract a large number of social media users, the market participants present various treatment processes in standard or short video forms. The market is expected to increase significantly over the forecast period due to the growing number of surgeons worldwide and the increasing adoption of technologically improved treatment equipment.
Competitive Landscape
The key players in the Non-Invasive Aesthetic Treatment market have shifted their focus toward technological advancement and higher demand for them. They are initiating significant strategies such as mergers and joint ventures of major and domestic players to expand their selection of products and raise their global market footprint. Some of the major key players in the Non-Invasive Aesthetic Treatment Market are :
- AbbVie
- Alma Lasers
- Merz Pharma
- Solta Medical
- Bausch Health Companies
- Candela
- Lumenis
- Sisram Medical
- Cutera
- Allergen
- Cynosure
- Fotona
- HTM Eletronica
- Johnson & Johnson
- Syneron Candela
Market Segmentation:
The Non-Invasive Aesthetic Treatment market is segmented based on gender, age group, type of procedure, and end-user. Based on gender, the market is segmented into Male and Female. By age group, the market is segmented into 13 to 39, 40 to 54, 55 to 69, and 70 or Above. By type of procedure, the market is segmented into Skin Rejuvenation (Laser Skin Resurfacing, Chemical Peel, and Photo-Rejuvenation), Injectable (Polymer Filler, Hyaluronic Acid, Collagen, Botulinum Toxin, and Calcium Hydroxylapatite), and Others (Sclerotherapy, Hair Removal, Non-surgical Fat reduction, and Cellulite Treatment). By end-user, the market is segmented into Hospitals & Surgery Centers, Traditional Spa, Medical Spa, and HCP Owned Clinics.
Based On The Type Of Procedure, The Injectable Segment Is Accounted As A Major Contributor To The Non-Invasive Aesthetic Treatment Market
The Injectable category is expected to hold a major global market share in 2021. Ongoing research and development projects as well as the launch of fresh, cutting-edge solutions by major industry participants committed to expanding the non-invasive aesthetic treatments LP market foster this expansion. These initiatives highlight the injectable industry's strategic focus on innovation and advancement, mirroring a larger trend in aesthetic medicine toward more varied and efficient treatment choices. For instance, Galderma's Restylane Contour was approved by the US Food and Drug Administration in June 2021 for the improvement of cheek augmentation and the restoration of midface contour defects.
Hospitals & Surgery Centers Segment To Witness Growth At A Rapid Rate
The market for non-invasive aesthetic treatments is dominated by the hospitals & surgery centers segment. Dermatologists and plastic surgeons are among the skilled medical specialists who can offer a variety of non-invasive aesthetic treatments at hospitals and surgery facilities. Due to the presence of skilled medical personnel, patients frequently favor these environments. Larger medical centres invest in cutting-edge facilities and equipment for non-invasive aesthetic treatments. This provides patients with access to cutting-edge procedures utilising sophisticated laser equipment, energy-based devices, and other advanced technologies.
In The Region, The North American Non-Invasive Aesthetic Treatment Market Holds A Significant Revenue Share
The North American Non-Invasive Aesthetic Treatment market is expected to register the highest market share in revenue shortly, driven by the public's growing awareness of non-invasive aesthetic treatments. According to the International Society of Aesthetic Plastic Surgery, the United States is the world's largest market for non-invasive aesthetic treatment. The US market was driven by the increasing adoption of technologically advanced procedures among the country's youth and elderly populations. In addition, Asia Pacific is projected to grow rapidly in the global Non-Invasive Aesthetic Treatment market. Growing disposable income and improved living standards have led consumers to spend more on non-invasive aesthetic treatments. Additionally, the demand for these procedures in the region has been fueled by the desire for Western beauty standards and an increasing knowledge of non-invasive therapies. Additionally, the non-invasive aesthetic treatment market is expected to experience significant expansion prospects due to the established presence of local enterprises in the area and an increase in research activities.
Non-Invasive Aesthetic Treatment Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 25.7 Bn |
|
Revenue Forecast In 2034 |
USD 63.8 Bn |
|
Growth Rate CAGR |
CAGR of 9.9% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Gender, Age Group, Type Of Procedure, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
AbbVie, Alma Lasers, Merz Pharma, Solta Medical, Bausch Health Companies, Candela, Lumenis, Sisram Medical, Cutera, Allergen, Cynosure,Fotona, HTM Eletronica, Johnson & Johnson, and Syneron Candela. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
